Volume 1 - Issue 1 - Sept/Oct 2004
Feature
Update
09/05/2008
Nicolas W. Shammas, MD, MS, FACC, FSCAI, FACP, FSVM
Despite the sharp rise in peripheral vascular interventions (PVI), complication rates have continued to be significant and, in fact, limb loss has trended upwards.
Despite the sharp rise in peripheral vascular interventions (PVI), complication rates have continued to be significant and, in fact, limb loss has trended upwards.
Despite the sharp rise in...
09/05/2008
Vascular Disease Management
Case Report
09/05/2008
Corey K. Goldman, MD, PhD
A 59-year-old hypertensive, diabetic, white male ex-smoker with a history of CABG in 1994. In 1997, he underwent insertion of a pacemaker for bradycardia. In 1999, he was diagnosed with squamous cell laryngeal cancer by biopsy.
A 59-year-old hypertensive, diabetic, white male ex-smoker with a history of CABG in 1994. In 1997, he underwent insertion of a pacemaker for bradycardia. In 1999, he was diagnosed with squamous cell laryngeal cancer by biopsy.
A 59-year-old hypertensive,...
09/05/2008
Vascular Disease Management
Original Research
09/05/2008
David E. Allie, MD; Chris J. Hebert, RRT, RCIS; Craig M. Walker, MD, FACC, FACP, FSCAI, FCCP
The TransAtlantic Inter-Societal Consensus committee and document on the management of peripheral arterial occlusive disease have recently attempted to unify and clarify CLI with the following recommendations.
The TransAtlantic Inter-Societal Consensus committee and document on the management of peripheral arterial occlusive disease have recently attempted to unify and clarify CLI with the following recommendations.
The TransAtlantic Inter-Societal...
09/05/2008
Vascular Disease Management
Case Report
09/05/2008
Multiple sequelae may occur after deep venous thrombosis (DVT), including acute limb symptoms such as swelling and pain, valvular damage and reflux leading to chronic symptoms, and, the most serious, pulmonary embolism and death.
Multiple sequelae may occur after deep venous thrombosis (DVT), including acute limb symptoms such as swelling and pain, valvular damage and reflux leading to chronic symptoms, and, the most serious, pulmonary embolism and death.
Multiple sequelae may occur...
09/05/2008
Vascular Disease Management
Case Report
09/05/2008
Intracranial angioplasty and stenting are increasingly being used to treat patients with recurrent cerebral ischemia due to intracranial atherosclerosis, which is a cause of 8-10% of all ischemic strokes.
Intracranial angioplasty and stenting are increasingly being used to treat patients with recurrent cerebral ischemia due to intracranial atherosclerosis, which is a cause of 8-10% of all ischemic strokes.
Intracranial angioplasty and...
09/05/2008
Vascular Disease Management
Original Research
09/05/2008
Dawn E. McKinney, MA; Monica Youngblut, RN; Eric J. Dippel, MD; Melodee Harris, RN, BSc; Vickie S. Takes, RT(R), CCRC, RN; Nicolas W. Shammas, MD, MS, FACC, FSCAI, FACP, FSVM; Jon H. Lemke, PhD, MD
Unfractionated heparin is the current antithrombotic agent utilized during peripheral angioplasty procedures.
Unfractionated heparin is the current antithrombotic agent utilized during peripheral angioplasty procedures.
Unfractionated heparin is the...
09/05/2008
Vascular Disease Management
Insights
Interview
09/05/2008
Phillip Purdy, MD
Just as we’ve been using the arteries as a conduit to navigate the vascular system for a long time, we also believe it may be possible to use the space surrounding the brain and spinal cord to navigate in and around the brain and spinal cord.
Just as we’ve been using the arteries as a conduit to navigate the vascular system for a long time, we also believe it may be possible to use the space surrounding the brain and spinal cord to navigate in and around the brain and spinal cord.
Just as we’ve been using the...
09/05/2008
Vascular Disease Management
Interview
09/05/2008
Michael R. Jaff, MD, DO; Gary M. Ansel, MD, FACC; Frank J. Criado, MD; Sandeep Khosla, MD, FACC, FSCAI; Nicolas W. Shammas, MD, MS, FACC, FSCAI, FACP, FSVM; David E. Allie, MD
In our experience, 40-50% of CLI patients will have SFA/popliteal involved and 30-40% in LACI trial.
In our experience, 40-50% of CLI patients will have SFA/popliteal involved and 30-40% in LACI trial.
In our experience, 40-50% of CLI...
09/05/2008
Vascular Disease Management
Column
Editor's Corner
09/05/2008
Frank J. Criado, MD
It is with a sense of pride and excitement that I set out to write the first Editor’s Letter for the inaugural issue of Vascular Disease Management (VDM).
It is with a sense of pride and excitement that I set out to write the first Editor’s Letter for the inaugural issue of Vascular Disease Management (VDM).
It is with a sense of pride and...
09/05/2008
Vascular Disease Management
